Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Michael Croft

23PUBLICATIONS

56CO-AUTHORS

Predictive and prognostic markersAllergyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (23)

Sort by Publication Date:

|Sep 19, 2025

LIGHT in combination with IL-13 or IL-17 drives inflammatory transcriptional signatures in human pulmonary fibroblasts relevant for human lung disease.

Nandita Ghosh, Rinkesh Kumar Gupta, Jeamin Jung

|Nov 26, 2024

Comparison of CD30L and OX40L Reveals CD30L as a Promising Therapeutic Target in Atopic Dermatitis.

Rinkesh K Gupta, Daniela Salgado Figueroa, Ferhat Ay

|Oct 25, 2024

Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer.

Michael Croft, Shahram Salek-Ardakani, Carl F Ware

|Feb 10, 2024

Correction to: OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.

Michael Croft, Ehsanollah Esfandiari, Camilla Chong

|Jan 18, 2024

OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.

Michael Croft, Ehsanollah Esfandiari, Camilla Chong

|Aug 31, 2023

TNF-like weak inducer of apoptosis inhibition is comparable to IL-13 blockade in ameliorating atopic dermatitis inflammation.

Rinkesh K Gupta, Jacqueline Miller, Michael Croft

Pageof 4

Frequent Collaborators

4 joint publications

Carl F Ware

3 joint publications

Shahram Salek-Ardakani

3 joint publications

Rana Herro

2 joint publications

Katarzyna Dobaczewska

2 joint publications

Emma Guttman-Yassky

2 joint publications

Richard B Warren

2 joint publications

Jianxun Song

2 joint publications

Jacqueline Miller

2 joint publications

Greg Kricorian

2 joint publications

Kenji Kabashima

Frequent Collaborators

4 joint publications

Carl F Ware

3 joint publications

Shahram Salek-Ardakani

3 joint publications

Rana Herro

2 joint publications

Katarzyna Dobaczewska

Top Related Videos

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on : Apr 16, 2019

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology

Published on : Jan 12, 2024

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

See more related videos

Top Related Videos

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on : Apr 16, 2019

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology

Published on : Jan 12, 2024

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

See more related videos